MBX Biosciences, Inc. (MBX) Stock Statistics & Valuation Metrics

MBX Biosciences, Inc. has a market cap or net worth of $3.14B. The enterprise value is $950.88.

MBX Biosciences, Inc. has 47,597,534 shares outstanding. The number of shares has decreased by -2.65% in one year.

MBX Biosciences, Inc.’s return on equity (ROE) is -0.24 and return on invested capital (ROIC) is -26.51%.

The current PE Ratio of MBX Biosciences, Inc. is ―. MBX Biosciences, Inc.’s PEG ratio is -0.46.

In the last 12 months, MBX Biosciences, Inc. had revenue of 0.00 and earned -86.97M in profits. Earnings per share was -2.38.

In the last 12 months, operating cash flow was -102.88M and capital expenditures -2.97M, giving a free cash flow of -105.84M billion.

MBX Biosciences, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―

MBX Biosciences, Inc. upcoming earnings date is Nov 5, 2026, Before Open (Confirmed).

MBX Biosciences, Inc. as a current ratio of 24.62, with Debt / Equity ratio of 0.82%

In the past 12 months, MBX Biosciences, Inc. has paid 0.00 in taxes.

MBX Biosciences, Inc. EV to EBITDA ratio is -12.42, with an EV/FCF ratio of -13.15.

MBX Biosciences, Inc. has $418.58M in cash and marketable securities with $3.34M in debt, giving a net cash position of $415.24M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for MBX Biosciences, Inc. is $87.50, which is 11.43% higher than the current price. The consensus rating is Strong Buy